4//SEC Filing
BioScrip, Inc. 4
Accession 0001127602-13-026471
$OPCHCIK 0001014739operating
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 5:15 PM ET
Size
17.9 KB
Accession
0001127602-13-026471
Insider Transaction Report
Form 4
BioScrip, Inc.BIOS
colucci daniel
Vice President, PBM Services
Transactions
- Exercise/Conversion
Common Stock, $.0001 Par Value
2013-08-29$2.73/sh+9,758$26,639→ 12,338 total - Sale
Common Stock, $.0001 Par Value
2013-08-30$12.32/sh−8,742$107,659→ 2,580 total - Exercise/Conversion
Common Stock, $.0001 Par Value
2013-08-30$2.73/sh+8,742$23,866→ 11,322 total - Exercise/Conversion
Employee Stock Option
2013-08-29−9,758→ 8,742 totalExercise: $2.73From: 2010-04-28Exp: 2019-04-28→ Common Stock, $.0001 Par Value (9,758 underlying) - Exercise/Conversion
Employee Stock Option
2013-08-30−8,742→ 0 totalExercise: $2.73From: 2010-04-28Exp: 2019-04-28→ Common Stock, $.0001 Par Value (8,742 underlying) - Sale
Common Stock, $.0001 Par Value
2013-08-29$12.47/sh−9,758$121,701→ 2,580 total
Holdings
- 5,500
Employee Stock Option
Exercise: $6.65From: 2011-06-16Exp: 2020-06-16→ Common Stock, $.0001 Par Value (5,500 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $11.04From: 2014-03-08Exp: 2023-03-08→ Common Stock, Par Value $0.0001 Per Share (50,000 underlying) - 20,000
Employee Stock Option
Exercise: $4.42From: 2012-04-26Exp: 2021-04-26→ Common Stock, $.0001 Par Value (20,000 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.45 to $12.53, inclusive. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.30 to $12.36, inclusive. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Fully Vested.
- [F4]Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
Documents
Issuer
BioScrip, Inc.
CIK 0001014739
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001014739
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 5:15 PM ET
- Size
- 17.9 KB